Literature DB >> 12746313

Substitution of cysteine for selenocysteine in the catalytic center of type III iodothyronine deiodinase reduces catalytic efficiency and alters substrate preference.

George G J M Kuiper1, Willem Klootwijk, Theo J Visser.   

Abstract

Human type III iodothyronine deiodinase (D3) catalyzes the conversion of T(4) to rT(3) and of T(3) to 3, 3'-diiodothyronine (T2) by inner-ring deiodination. Like types I and II iodothyronine deiodinases, D3 protein contains selenocysteine (SeC) in the highly conserved core catalytic center at amino acid position 144. To evaluate the contribution of SeC144 to the catalytic properties of D3 enzyme, we generated mutants in which cysteine (D3Cys) or alanine (D3Ala) replaces SeC144 (D3wt). COS cells were transfected with expression vectors encoding D3wt, D3Cys, or D3Ala protein. Kinetic analysis was performed on homogenates with dithiothreitol as reducing cofactor. The Michaelis constant of T(3) was 5-fold higher for D3Cys than for D3wt protein. In contrast, the Michaelis constant of T(4) increased 100-fold. The D3Ala protein was enzymatically inactive. Semiquantitative immunoblotting of homogenates with a D3 antiserum revealed that about 50-fold higher amounts of D3Cys and D3Ala protein are expressed relative to D3wt protein. The relative substrate turnover number of D3Cys is 2-fold reduced for T(3) and 6-fold reduced for T(4) deiodination, compared with D3wt enzyme. Studies in intact COS cells expressing D3wt or D3Cys showed that the D3Cys enzyme is also active under in situ conditions. In conclusion, the SeC residue in the catalytic center of D3 is essential for efficient inner-ring deiodination of T(3) and in particular T(4) at physiological substrate concentrations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746313     DOI: 10.1210/en.2003-0084

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  23 in total

1.  Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy.

Authors:  Orly Agamy; Bruria Ben Zeev; Dorit Lev; Barak Marcus; Dina Fine; Dan Su; Ginat Narkis; Rivka Ofir; Chen Hoffmann; Esther Leshinsky-Silver; Hagit Flusser; Sara Sivan; Dieter Söll; Tally Lerman-Sagie; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

Review 2.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

3.  Enzyme mimics: halogen and chalcogen team up.

Authors:  Pierangelo Metrangolo; Giuseppe Resnati
Journal:  Nat Chem       Date:  2012-05-22       Impact factor: 24.427

4.  Type 3 deiodinase is critical for the maturation and function of the thyroid axis.

Authors:  Arturo Hernandez; M Elena Martinez; Steven Fiering; Valerie Anne Galton; Donald St Germain
Journal:  J Clin Invest       Date:  2006-01-12       Impact factor: 14.808

Review 5.  On elongation factor eEFSec, its role and mechanism during selenium incorporation into nascent selenoproteins.

Authors:  Miljan Simonović; Anupama K Puppala
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-03-17       Impact factor: 3.770

6.  Imprinting analysis of porcine DIO3 gene in two fetal stages and association analysis with carcass and meat quality traits.

Authors:  Mu Qiao; Hua-Yu Wu; Ling Guo; Shu-Qi Mei; Peng-Peng Zhang; Feng-E Li; Rong Zheng; Chang-Yan Deng
Journal:  Mol Biol Rep       Date:  2011-06-10       Impact factor: 2.316

7.  Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells.

Authors:  Iuri Martin Goemann; Balázs Gereben; John W Harney; Bo Zhu; Ana Luiza Maia; P Reed Larsen
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

8.  Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration.

Authors:  Fan Yang; Hongwei Ma; Joshua Belcher; Michael R Butler; T Michael Redmond; Sanford L Boye; William W Hauswirth; Xi-Qin Ding
Journal:  FASEB J       Date:  2016-09-13       Impact factor: 5.191

Review 9.  Functions and evolution of selenoprotein methionine sulfoxide reductases.

Authors:  Byung Cheon Lee; Alexander Dikiy; Hwa-Young Kim; Vadim N Gladyshev
Journal:  Biochim Biophys Acta       Date:  2009-05-04

10.  Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10.

Authors:  Edith C H Friesema; Jurgen Jansen; Jan-Willem Jachtenberg; W Edward Visser; Monique H A Kester; Theo J Visser
Journal:  Mol Endocrinol       Date:  2008-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.